Business

Curis Provides First Quarter 2026 Business Update

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule...

U2Fx.comU2Fx.com
May 13, 2026 - 01:00
 0  2
Curis Provides First Quarter 2026 Business Update
/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule...
Read More

Tags:

Previous Article

Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides B...

Next Article

Baton Rouge entrepreneur rebuilds life one loaf at a time

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

U2Fx.com
U2Fx.com

Related Posts

Bangkok Wakes to Toxic Air Choking Central Business Districts

Bangkok Wakes to Toxic Air Choking Central Business Dis...

U2Fx.com Jan 14, 2026  0  22

Voices: North Miami Beach to hold small business summit and expo

Voices: North Miami Beach to hold small business summit...

U2Fx.com May 3, 2026  0  9

How unplanned snow days impact small central Ohio businesses

How unplanned snow days impact small central Ohio busin...

U2Fx.com Jan 29, 2026  0  17